Press release
Emerging Breast Cancer Monoclonal Antibodies Market Trend 2025-2034: Popularity Of Alternative And Natural Cancer Treatments
Breast Cancer Monoclonal Antibodies Market Size
The market for breast cancer monoclonal antibodies has witnessed significant growth in the past few years. The market value is anticipated to expand from $18.97 billion in 2024 to $20.18 billion in 2025, marking a compound annual growth rate (CAGR) of 6.4%. This positive trend during the historic interval can be ascribed to factors such as the escalating incidence of breast cancer, enhanced understanding of breast cancer monoclonal antibodies, improved clinical effectiveness, and increased demand from patients.
The market for breast cancer monoclonal antibodies is projected to witness robust expansion in the forthcoming years. The market value is predicted to reach $27.8 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.3%. The surge in growth during this forecast period is linked to developments in emerging targets, biosimilars, combination therapies, the global prevalence and an aging population, and personalised medicine. The forecast period is marked by considerable trends such as progress in early detection of breast cancer, integration of immunotherapy, liquid biopsies, companion diagnostics, adjuvant and neoadjuvant therapies, as well as long-term survivorship support.
What Are the Key Drivers Behind the Growth of the Breast Cancer Monoclonal Antibodies Market?
The surge in breast cancer cases is anticipated to propel the growth of the breast cancer monoclonal antibody market. For example, the American Cancer Society, a nonprofit cancer advocacy organization located in the US, revealed in January 2023 that the number of breast cancer cases climbed from 284,200 in 2021 to 300,590 in 2023, indicating a 5.76% rise. Therefore, the escalating global prevalence of breast cancer is likely to stimulate the expansion of the breast cancer monoclonal antibody market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3450&type=smp
Who Are the Major Industry Players Fueling Breast Cancer Monoclonal Antibodies Market Expansion?
Major companies operating in the breast cancer monoclonal antibodies market include Amgen Inc., Mylan N.V., Merck & Co. Inc., Novartis AG, GlaxoSmithKline plc., Daiichi Sankyo Company Ltd., Biocad, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Celldex Therapeutics Inc., Celltrion Inc., F. Hoffmann-La Roche AG, Immunomedics Inc., MacroGenics Inc., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Puma Biotechnology Inc., Seattle Genetics Inc., AstraZeneca plc, Eddingpharm, Eisai Co. Ltd., ImmunoGen Inc., Eli Lilly and Company, AbbVie Inc., Johnson & Johnson, Mersana Therapeutics Inc., Immunocore Limited, Immunovative Therapies Ltd.
Which Key Developments Are Influencing the Breast Cancer Monoclonal Antibodies Market?
There is an emerging global trend towards alternative treatments and natural remedies which is anticipated to influence the earnings of firms manufacturing monoclonal antibodies for breast cancer. Techniques stemming from homeopathy, Ayurveda, yoga, acupuncture, and sujok therapy are becoming sought after replacements for some conventional hospital measures. For example, ayurvedic medicine, a traditional Indian medical approach, uses a variety of methods and cancer treatments. Numerous herbs employed in Ayurveda possess anti-cancer qualities. The World Health Organization (WHO) reports that certain countries still rely primarily on plant-based treatments, and emerging economies are harnessing the therapeutic potential of natural compounds, consequently impacting pharmaceutical oncology sales. In addition, it is estimated that by 2027, the worldwide market for homeopathic products will amount to $18.6 billion. The National Cancer Institute has highlighted the promising results of vaccines in combating HER2-positive cancers such as breast, ovarian, lung, colorectal and gastroesophageal cancers, using patients' genetically-modified immune cells to create personalized vaccines. As these trends continue into the forecast period, a dampening effect on the demand for breast cancer monoclonal antibodies is expected.
How Is the Segmentation of the Breast Cancer Monoclonal Antibodies Market Defined?
The breast cancer monoclonal antibodies market covered in this report is segmented -
1) By Product: Naked Mabs, Conjugated Mabs
2) By Treatment: Chemotherapy, Surgery & Radiation Therapy, Targeted Therapy, Biologic Therapy, Hormone Therapy
3) By End-User: Hospitals, Retail Pharmacies
Subsegments:
1) By Naked MABs: Trastuzumab (Herceptin), Rituximab, Cetuximab, Other Naked MABs
2) By Conjugated MABs: Ado-trastuzumab emtansine (Kadcyla), Brentuximab vedotin, Other Conjugated MABs
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/breast-cancer-monoclonal-antibodie-global-market-report
What Is the Leading Region in the Breast Cancer Monoclonal Antibodies Market?
The countries covered in the breast cancer monoclonal antibodies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
What Is Covered In The Breast Cancer Monoclonal Antibodies Global Market Report?
- Market Size Analysis: Analyze the Breast Cancer Monoclonal Antibodies Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Breast Cancer Monoclonal Antibodies Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Breast Cancer Monoclonal Antibodies Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Breast Cancer Monoclonal Antibodies Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3450
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Emerging Breast Cancer Monoclonal Antibodies Market Trend 2025-2034: Popularity Of Alternative And Natural Cancer Treatments here
News-ID: 3931487 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
